Orofaciodigital syndrome type 3

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2752OMIM:258850
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Orofaciodigital syndrome type 3 (OFD3), also known as Sugarman syndrome, is an extremely rare genetic disorder characterized by abnormalities of the mouth (oral), face (facial), and fingers and toes (digital). This condition was first described by Sugarman and colleagues in 1971. Key clinical features include abnormalities of the teeth (such as supernumerary or malpositioned teeth), lobulated tongue or tongue hamartomas, cleft lip and/or palate, and digital anomalies including postaxial polydactyly and clinodactyly. Facial features may include a broad nasal root and other midface abnormalities. A distinguishing feature of OFD3 compared to other orofaciodigital syndromes is the association with significant intellectual disability and characteristic eye findings including myopia. Skeletal abnormalities may also be present. OFD3 affects multiple body systems including the craniofacial structures, the central nervous system, the skeletal system, and the eyes. The condition is apparent at birth or early infancy due to the visible oral, facial, and digital malformations. There is no specific cure or targeted therapy for OFD3. Management is supportive and symptomatic, typically involving a multidisciplinary team including oral and maxillofacial surgeons, orthopedic specialists, ophthalmologists, and developmental specialists. Surgical correction of cleft lip/palate, dental anomalies, and polydactyly may be performed as needed. Early intervention programs and educational support are important for addressing intellectual disability. Due to the extreme rarity of this condition, with only a handful of reported cases in the medical literature, knowledge about the full clinical spectrum and long-term prognosis remains limited.

Also known as:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Orofaciodigital syndrome type 3.

View clinical trials →

No actively recruiting trials found for Orofaciodigital syndrome type 3 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Orofaciodigital syndrome type 3 community →

No specialists are currently listed for Orofaciodigital syndrome type 3.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Orofaciodigital syndrome type 3.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Orofaciodigital syndrome type 3Forum →

No community posts yet. Be the first to share your experience with Orofaciodigital syndrome type 3.

Start the conversation →

Latest news about Orofaciodigital syndrome type 3

No recent news articles for Orofaciodigital syndrome type 3.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Orofaciodigital syndrome type 3

What is Orofaciodigital syndrome type 3?

Orofaciodigital syndrome type 3 (OFD3), also known as Sugarman syndrome, is an extremely rare genetic disorder characterized by abnormalities of the mouth (oral), face (facial), and fingers and toes (digital). This condition was first described by Sugarman and colleagues in 1971. Key clinical features include abnormalities of the teeth (such as supernumerary or malpositioned teeth), lobulated tongue or tongue hamartomas, cleft lip and/or palate, and digital anomalies including postaxial polydactyly and clinodactyly. Facial features may include a broad nasal root and other midface abnormalities

How is Orofaciodigital syndrome type 3 inherited?

Orofaciodigital syndrome type 3 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Orofaciodigital syndrome type 3 typically begin?

Typical onset of Orofaciodigital syndrome type 3 is neonatal. Age of onset can vary across affected individuals.